Generic losartan to hit U.S. shelves
The FDA has approved losartan potassium tablets, a generic version of Merk’s Cozaar/Hyzaar, in 25 mg, 50 mg and 100 mg strength, for marketing in the U.S.

Losartan potassium is an angiotensin II receptor antagonist indicated to treat hypertension that can be used alone or in combination with other antihypertensive agents, including diuretics.

According to IMS Health, losartan potassium tablets saw U.S. sales reach an estimated $940 million for the 12 months, which ended June 30.

Actavis Group of Hafnarfjörour, Iceland, and Mylan Pharmaceuticals of Pittsburgh will commercially sell the generic drug in the U.S.